Involved in mRNA degradation. Catalyzes the processive 3'- to 5'-direction phosphorolysis of single-stranded polyribonucleotides.
KEGG: efa:EF3064
STRING: 226185.EF3064
Polyribonucleotide nucleotidyltransferase (PNPase, EC 2.7.7.8) in E. faecalis is an enzyme involved in RNA metabolism with both 3'-5' exoribonuclease activity and template-independent polymerase activity. This bifunctional enzyme plays crucial roles in RNA turnover, quality control mechanisms, and post-transcriptional regulation. In E. faecalis, a gram-positive bacterium that inhabits diverse environments including the human intestine, PNPase contributes to environmental adaptation and potentially to virulence mechanisms. The recombinant partial protein is derived from E. faecalis strain ATCC 700802/V583, which belongs to a high-risk clonal complex particularly well-adapted to hospital environments .
For optimal stability and activity retention, recombinant E. faecalis PNPase requires specific storage conditions based on its formulation:
| Formulation | Recommended Storage | Shelf Life |
|---|---|---|
| Liquid form | -20°C to -80°C | 6 months |
| Lyophilized form | -20°C to -80°C | 12 months |
Repeated freeze-thaw cycles significantly decrease protein activity and should be avoided. After reconstitution, working aliquots can be stored at 4°C for up to one week. For long-term storage, adding glycerol to a final concentration of 50% and storing at -20°C to -80°C is recommended . When planning long-term experiments, researchers should consider these stability limitations and prepare appropriately sized aliquots to minimize freeze-thaw cycles.
For optimal reconstitution of lyophilized recombinant E. faecalis PNPase:
Briefly centrifuge the vial prior to opening to bring contents to the bottom
Reconstitute in deionized sterile water to achieve a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration between 5-50% for enhanced stability
Prepare small working aliquots to avoid repeated freeze-thaw cycles
For immediate use, store working aliquots at 4°C (stable for up to one week)
The reconstitution buffer can be modified according to specific experimental requirements, but significant deviations from neutral pH or physiological salt concentrations may affect protein activity . When designing reconstitution protocols, consider the downstream applications and potential buffer incompatibilities.
Experimental Protocol for PNPase Activity Assay:
Degradation Assay:
Prepare reaction mixture containing:
20 mM Tris-HCl (pH 7.5)
5 mM MgCl₂
1 mM DTT
0.1 mM EDTA
10% glycerol
0.5-1 μg recombinant PNPase
5'-labeled RNA substrate (0.5-1 pmol)
Incubate at 37°C for 5-30 minutes
Analyze reaction products by denaturing PAGE and autoradiography
Polymerization Assay:
Prepare reaction mixture containing:
20 mM Tris-HCl (pH 7.5)
5 mM MgCl₂
1 mM DTT
0.1 mM EDTA
10% glycerol
0.5-1 μg recombinant PNPase
3'-labeled RNA substrate (0.5-1 pmol)
1 mM ADP/GDP/CDP/UDP as substrate
Incubate at 37°C for 15-60 minutes
Analyze reaction products by denaturing PAGE and autoradiography
Both assays should include appropriate controls such as heat-inactivated enzyme and time-point samples to establish reaction kinetics. The partially purified recombinant protein may contain trace contaminants that could affect assay outcomes, so running parallel reactions with commercially available PNPase from other species as standards is recommended.
To study E. faecalis PNPase function in vivo, researchers can use E. coli-E. faecalis shuttle vectors such as pAM401-based systems. This methodology allows for both complementation studies and protein overexpression:
Construction of PNPase expression vector:
Clone the pnp gene into a shuttle vector such as pMGS100 or pMGS101 under the control of the bacA promoter
For protein purification purposes, use pMGS101 which contains a Strep-tag sequence for affinity purification
Transform the construct into E. coli for propagation and verification
Expression in E. faecalis:
Transfer the verified construct into E. faecalis strains
For complementation studies, use a pnp deletion mutant
For overexpression studies, use wild-type strains
Functional analysis options:
RNA decay assays comparing wild-type, deletion mutant, and complemented strains
Stress response assays under various environmental conditions
Virulence assays in infection models
This approach has been successfully used for other E. faecalis proteins and allows for cis/trans analysis of gene function . When selecting a vector system, consider compatibility with the specific E. faecalis strain being used and potential effects of antibiotics used for selection.
The role of PNPase in E. faecalis stress response can be investigated using a multi-faceted approach:
| Stress Condition | Methodology | Readout |
|---|---|---|
| Temperature stress | Growth curves at various temperatures (25°C, 37°C, 42°C, 45°C) | OD600 measurements, survival rates |
| Acid stress | Growth in media at different pH values (pH 4.5, 5.5, 7.0) | Survival rates, gene expression analysis |
| Oxidative stress | Exposure to H₂O₂ or superoxide generators | Survival assays, enzymatic activity measurements |
| Antibiotic stress | Growth in sub-inhibitory concentrations of antibiotics | MIC determination, growth kinetics |
For each condition, compare:
Wild-type E. faecalis
pnp deletion mutant
Complemented strain (expressing recombinant PNPase)
Overexpression strain
Additional analyses should include:
RNA stability assays using rifampicin chase experiments
qRT-PCR to measure expression of stress response genes
RNA-seq to identify global effects on transcriptome
Protein-RNA interaction studies using RNA immunoprecipitation
E. faecalis is known for its ability to tolerate diverse environmental conditions, making it an excellent model for studying stress response mechanisms . The stress conditions should be carefully optimized for each experimental system to ensure reproducible results.
While direct evidence for E. faecalis PNPase in virulence is limited in the provided search results, research on related bacterial species suggests several potential mechanisms:
Post-transcriptional regulation of virulence factors:
PNPase likely regulates the stability of mRNAs encoding virulence factors. This can be investigated by:
Comparing virulence gene expression profiles between wild-type and pnp mutant strains
Analyzing direct binding of PNPase to virulence factor mRNAs using CLIP-seq
Measuring half-lives of virulence factor transcripts in the presence/absence of PNPase
Stress adaptation during infection:
E. faecalis encounters various stresses during infection, and PNPase may facilitate adaptation:
Within the gastrointestinal tract (acid stress, bile stress)
During endocarditis development (shear stress, immune response)
In urinary tract infections (osmotic stress)
Interaction with prophage elements:
E. faecalis V583 harbors multiple prophage elements that contribute to pathogenicity. PNPase may regulate prophage gene expression or activation:
Experimental approaches should include infection models comparing wild-type and pnp mutant strains, focusing on:
Colonization efficiency in various niches
Persistence during antibiotic treatment
Biofilm formation capacity
Adhesion to host tissues and platelets
The relationship between PNPase and antibiotic resistance in E. faecalis represents an important research area with clinical implications:
Post-transcriptional regulation of resistance genes:
PNPase may regulate the stability and expression of antibiotic resistance genes
RNA processing could affect expression of efflux pumps, cell wall modification enzymes, and other resistance determinants
Stress response coordination:
Antibiotic exposure triggers bacterial stress responses
PNPase regulation of stress-responsive transcripts may indirectly affect resistance development
Biofilm formation and persistence:
E. faecalis forms biofilms that contribute to antibiotic tolerance
PNPase may regulate genes involved in biofilm matrix production and cellular aggregation
Prophage-mediated resistance transfer:
Research approach:
Compare wild-type and pnp mutant strains for:
MIC values for various antibiotic classes
Time-kill kinetics under antibiotic pressure
Development of resistance during serial passage
Expression of known resistance genes
Biofilm formation capacity under antibiotic stress
E. faecalis is a significant nosocomial pathogen partially due to its widespread antibiotic resistance, including vancomycin resistance . Understanding PNPase's role could provide insights into resistance mechanisms and potential intervention strategies.
Structural analysis of E. faecalis PNPase reveals important similarities and differences compared to homologs in other bacteria:
Structural features comparison:
Experimental approaches for structural analysis:
Homology modeling:
Using existing PNPase structures as templates
Identifying conserved functional domains and species-specific regions
Biochemical characterization:
Limited proteolysis to identify domain boundaries
Circular dichroism for secondary structure analysis
Thermal stability assays comparing full-length vs. partial constructs
Domain-specific functional analysis:
Construction of truncated variants lacking specific domains
Site-directed mutagenesis of catalytic residues
RNA binding assays with different substrate types
Based on the partial nature of the recombinant protein described in the search results , careful consideration of which domains are present in the construct is essential for experimental design and interpretation of results. The UNIPROT entry (Q82ZJ2) can provide further details on the complete protein sequence and domain organization.
Researchers commonly encounter several challenges when working with recombinant E. faecalis PNPase:
| Issue | Potential Causes | Solutions |
|---|---|---|
| Low protein activity | Improper storage, denaturation during purification | Store at -80°C with 50% glycerol; add reducing agents to buffers |
| Aggregation | Improper buffer conditions, high concentration | Optimize buffer components; maintain protein below critical concentration |
| Contaminating nuclease activity | Co-purified host proteins | Include additional purification steps; use nuclease inhibitors |
| Batch-to-batch variability | Expression conditions, purification differences | Standardize production protocols; use activity assays for QC |
| Limited stability | Protease contamination, oxidation | Add protease inhibitors; include reducing agents |
Quality control recommendations:
Verify protein purity by SDS-PAGE (should be >85% as specified in the product information)
Confirm identity by western blot using anti-PNPase antibodies
Perform activity assays before experimental use
Monitor stability over time under working conditions
Include appropriate controls in all experiments
For the partial recombinant protein, understanding which domains are present and functional is crucial. If certain domains are missing, protein activity may be compromised or altered compared to the full-length native protein.
Distinguishing between the dual activities of PNPase requires careful experimental design:
1. Buffer optimization:
Different buffer conditions can favor one activity over the other:
Exonuclease activity: Higher phosphate concentrations (5-10 mM)
Polymerase activity: Higher ADP concentrations (1-2 mM)
2. Substrate design:
For exonuclease assays: Use 5'-labeled RNA substrates with structured 3' ends
For polymerase assays: Use 3'-labeled RNA with accessible 3' ends
3. Selective inhibition:
Citrate preferentially inhibits polymerase activity
High Mg²⁺ concentrations (>10 mM) favor exonuclease activity
4. Site-directed mutagenesis:
Create variants with mutations in:
Phosphorolytic active site (to eliminate exonuclease activity)
Polymerization active site (to eliminate polymerase activity)
5. Assay readouts:
Exonuclease activity: Measure release of nucleotides using TLC or HPLC
Polymerase activity: Detect elongation of RNA substrates by PAGE
Understanding these dual activities is crucial for interpreting PNPase's role in bacterial RNA metabolism and regulatory networks. When working with the partial recombinant protein, researchers should determine which catalytic sites are present in the construct before designing activity assays.
Proper validation of PNPase knockout and complemented strains is essential for reliable research:
For PNPase knockout validation:
Genetic confirmation:
PCR verification using primers flanking the deletion site
Sequencing across the deletion junction
Southern blot analysis to confirm single integration events
Expression analysis:
RT-PCR to confirm absence of pnp transcript
Western blot to verify absence of PNPase protein
RNA-seq to identify potential polar effects on nearby genes
Phenotypic characterization:
Growth curves under standard conditions
Stress response profiling
RNA decay assays using model substrates
For complementation strain validation:
Expression verification:
RT-PCR to confirm pnp transcript levels
Western blot to verify PNPase protein production
Activity assays to confirm functional enzyme
Genetic stability:
Plasmid maintenance under non-selective conditions
Copy number determination
Sequencing to confirm absence of mutations
Phenotype restoration:
Comparison to wild-type in all relevant assays
Dose-dependency analysis if using inducible promoters
Growth characteristics under various conditions
When creating E. faecalis mutants, researchers can utilize approaches similar to those described for other E. faecalis genes, such as homologous recombination techniques . E. coli-E. faecalis shuttle vectors like pAM401-based systems can be used for complementation studies . The choice of vector system should consider factors like copy number, promoter strength, and stability in the absence of selection.
RNA-seq experimental design for studying PNPase function requires specific considerations:
Sample preparation protocol:
Strain preparation:
Wild-type E. faecalis
pnp knockout mutant
Complemented strain
PNPase overexpression strain
Growth conditions:
Standard laboratory conditions (BHI, 37°C)
Relevant stress conditions (acid, oxidative, antibiotic)
Growth phase considerations (exponential vs. stationary)
RNA extraction optimizations:
Rapid sample processing to minimize RNA degradation
DNase treatment to remove genomic DNA
rRNA depletion to enrich for mRNA and sRNAs
Size selection to capture small RNAs (<200 nt)
Library preparation considerations:
Directional libraries to distinguish sense and antisense transcripts
5'-end capture methods to identify processing sites
3'-end sequencing to detect tailing and degradation intermediates
Data analysis pipeline:
Quality control and preprocessing
Mapping to E. faecalis genome (strain V583 recommended as reference)
Differential expression analysis (DESeq2 or similar tools)
RNA stability calculations from time-course data
Motif discovery in differentially regulated transcripts
Pathway enrichment analysis
Validation experiments:
Northern blotting for selected targets
qRT-PCR validation of expression changes
RNA stability assays using rifampicin chase
RNA immunoprecipitation to identify direct PNPase targets
This approach allows comprehensive characterization of PNPase's impact on RNA processing, degradation, and gene expression in E. faecalis .
Several complementary techniques can identify direct RNA targets of E. faecalis PNPase:
1. RNA Immunoprecipitation (RIP):
Cross-link RNA-protein complexes in vivo
Lyse cells and immunoprecipitate PNPase with specific antibodies
Extract and analyze bound RNAs by sequencing or microarray
2. CLIP-seq (Cross-Linking Immunoprecipitation followed by sequencing):
UV cross-linking to capture direct RNA-protein interactions
Immunoprecipitation of PNPase
Partial RNase digestion to identify binding sites
Library preparation and high-throughput sequencing
Bioinformatic analysis to identify binding motifs
3. In vitro binding assays:
Gel shift assays with purified recombinant PNPase and candidate RNAs
Filter binding assays to determine binding affinities
Competition assays to identify high-affinity substrates
4. Gradient fractionation:
Separate cellular components by density
Analyze co-fractionation of PNPase and specific RNAs
Compare wild-type and catalytically inactive mutants
5. Structural analysis of complexes:
Hydrogen-deuterium exchange mass spectrometry
Chemical probing of RNA structure in the presence/absence of PNPase
Cryo-EM of PNPase-RNA complexes
When using the partial recombinant protein , researchers should verify that RNA-binding domains are present in the construct. Comparison with full-length native protein may be necessary to validate binding results.
Investigation of PNPase's role in biofilm formation and virulence requires a multi-faceted approach:
Biofilm formation assays:
Static biofilm models:
Microtiter plate crystal violet assay
Confocal microscopy with fluorescent strains
Biomass and viability quantification
Flow cell biofilm models:
Real-time visualization of biofilm development
Analysis of structural parameters (thickness, roughness)
Response to antimicrobial challenges
Mixed-species biofilms:
Co-culture with other oral or intestinal bacteria
Competition and cooperation dynamics
Species distribution analysis by FISH or qPCR
Virulence assays:
Adhesion to relevant tissues:
Human platelets (for endocarditis models)
Intestinal epithelial cells
Urinary tract epithelial cells
Resistance to host defenses:
Survival in human serum
Resistance to phagocytosis
Survival within macrophages
Animal infection models:
Caenorhabditis elegans killing assay
Galleria mellonella infection model
Mouse models of bacteremia or endocarditis
Molecular mechanisms investigation:
Transcriptome analysis:
RNA-seq of biofilm vs. planktonic cells
Comparison of wild-type vs. pnp mutant
Identification of PNPase-regulated virulence factors
Regulatory network analysis:
ChIP-seq of relevant transcription factors
Two-component system phosphorylation assays
quorum sensing molecule quantification
E. faecalis prophages contribute to adhesion to human platelets, a critical step in endocarditis development . Investigating potential interactions between PNPase and prophage regulation could reveal novel aspects of virulence control.